Breaking News Instant updates and real-time market news.

MCK

McKesson

$148.29

2.005 (1.37%)

, ESRX

Express Scripts

$75.55

2.11 (2.87%)

16:59
04/23/18
04/23
16:59
04/23/18
16:59

Glenview's Robbins says he likes McKesson

Says McKesson (MCK), Express Scripts (ESRX), CVS (CVS) trading at historically low multiples. Larry Robbins, founder, portfolio manager and CEO, Glenview Capital Management is presenting at the 2018 Sohn Investment Conference.

MCK

McKesson

$148.29

2.005 (1.37%)

ESRX

Express Scripts

$75.55

2.11 (2.87%)

CVS

CVS Health

$65.69

0.58 (0.89%)

  • 02

    May

  • 02

    May

  • 12

    Jun

  • 12

    Jun

MCK McKesson
$148.29

2.005 (1.37%)

04/17/18
MZHO
04/17/18
NO CHANGE
MZHO
Amazon news removes 'unprecedented overhang' on drug sellers, says Mizuho
After CNBC reported yesterday afternoon that Amazon (AMZN) has decided to shelve its plan to sell and distribute pharmaceutical products, Mizuho analyst Ann Hynes said she had thought Amazon's current logistics and distribution model would not translate into healthcare. However, based on conversations with investors, she believes the magnitude of the overhang that Amazon presented for drug distributors and retail pharmacies was "unprecedented." While drug pricing is still a concern, she notes that the CNBC report removes one overhang on the drug supply chain stocks. Hynes remain a buyer of CVS Health (CVS) and Walgreens (WBA) and keeps Neutral ratings on Rite Aid (RAD) as well as on drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK).
03/08/18
LEHM
03/08/18
INITIATION
Target $165
LEHM
Equal Weight
McKesson initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started McKesson with an Equal Weight rating and $165 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
Buy
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
ESRX Express Scripts
$75.55

2.11 (2.87%)

04/17/18
LEER
04/17/18
NO CHANGE
LEER
Amazon, Trump news positive for drug supply chain, distributors, says Leerink
Leerink analyst Ana Gupte sees the dual pronged news flow on Amazon (AMZN) being unlikely to enter the Hospital drug supply chain, and President Trump poised to give a speech on drug pricing and supply chain reform on April 26 as HHS Secretary Alex Azar solicits ideas for pricing reform as positive for both the drug supply chain across PBMs and drug distributors and biopharma manufacturers that have been roiled by fears of margin compression on both these threats. Within her coverage, the analyst views this as positive for UnitedHealth (UNH) with its Optum Rx PBM, Cigna (CI) with its deal to acquire Express Scripts (ESRX), and Aetna (AET) which has inked a deal with CVS (CVS) in part through equity, as well as Anthem (ANTM) with IngenioRx and Humana (HUM) with or without its potential Walmart (WMT) deal that has a sizable mail order operation.
04/02/18
LEER
04/02/18
NO CHANGE
LEER
Possible Humana/Walmart deal transformational for U.S. seniors market, says Leerink
Leerink analyst Ana Gupte sees the possible Humana (HUM)-Walmart (WMT) deal as transformational for the U.S. Seniors market and estimates the deal value at close to $50B. The analyst also believes the deal helps Humana compete more effectively with UnitedHealth (UNH)/Optum and Aetna (AET)-CVS (CVS), while Walmart can also compete with Amazon (AMZN) that is eroding sales and likely eyeing an entry into the Prescription Rx market. Gupte expects the anti-trust scrutiny of three deals Aetna-CVS, Cigna (CI)-Express Scripts (ESRX) and Humana-Walmart by the DOJ will be more challenged under simultaneous review by the DOJ, though Walmart and Humana have the least anti-competitive issues. Humana-Walmart could catalyze a counter-offer for Cigna from Walgreens Boots Alliance (WBA) or even Amazon, or re-invigorate Walgreens-AmerisourceBergen (ABC) talks, she contends.
03/15/18
DBAB
03/15/18
NO CHANGE
Target $236
DBAB
Buy
Cigna shares look oversold with or without deal, says Deutsche Bank
Cigna (CI) shares are down 26% from the January $226 high and 14% since the Express Scripts (ESRX) deal was announced on March 8, Deutsche Bank analyst Chris Rigg tells investors in a research note. The analyst estimates pro forma 2021 earnings per share of $21.18 for Cigna and Express Scripts. As such, he sees "ample conservatism" in management's 2021 EPS target range of $20-$21. With or without the deal, Cigna shares look oversold, Rigg contends. He keeps a Buy rating on Cigna with a $236 price target.
CVS CVS Health
$65.69

0.58 (0.89%)

04/10/18
LEER
04/10/18
NO CHANGE
Target $85
LEER
Outperform
CVS drug trend report highlights value of PBM model, says Leerink
Leerink analyst David Larsen notes that CVS recently published its 2017 drug trend report, and reported good performance, posting total drug trend of +1.9%. In his view, this trend which is a five-year low, and the 0.2% reported drug price growth, is evidence that the PBM business model delivers significant value to clients. The analyst is generally positive on the PBM business model, and despite constant "noise" around transparency and drug costs, he believes the proof is in the trend. Larsen reiterates an Outperform rating and $85 price target on the shares.
04/05/18
CHLM
04/05/18
NO CHANGE
Target $30
CHLM
Hold
CVS focusing on home dialysis positive for NxStage Medical, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich notes that CVS Health (CVS) announced an initiative to improve patient outcomes for chronic kidney disease and dialysis. The analyst believes that a company of CVS Health's size and stature focusing on home dialysis and specifically home hemodialysis is a positive for NxStage Medical (NXTM) since it is the market leader with a huge head start. While there could be concerns about price competition if and when CVS Health is able to get a home hemodialysis device to market, NxStage Medical will have its next generation products to market, as well as a peritoneal dialysis machine, he contends, adding that he thinks the market opportunity will be much larger. Ellich reiterates a Hold rating and $30 price target on NxStage Medical's shares.

TODAY'S FREE FLY STORIES

BAYRY

Bayer

$0.00

(0.00%)

15:22
12/10/18
12/10
15:22
12/10/18
15:22
Periodicals
Bayer CEO says has not had communication with Elliott, Reuters says »

According to a recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$20.74

-0.56 (-2.63%)

15:20
12/10/18
12/10
15:20
12/10/18
15:20
Options
Put spreads in US Steel as shares slip to 52-week lows »

Put spreads in US Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASY

Casey's General Stores

$119.48

-1.94 (-1.60%)

15:19
12/10/18
12/10
15:19
12/10/18
15:19
Options
Caseys General Stores options imply 9.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/10/18
12/10
15:17
12/10/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/10/18
12/10
15:16
12/10/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$16.18

-0.4 (-2.41%)

15:10
12/10/18
12/10
15:10
12/10/18
15:10
Options
DOOM puts opened in Hertz »

DOOM puts opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEMI

Chembio Diagnostics

$6.35

0.01 (0.16%)

15:05
12/10/18
12/10
15:05
12/10/18
15:05
Hot Stocks
Breaking Hot Stocks news story on Chembio Diagnostics »

Cortina Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPAR

Spartan Motors

$7.31

0.16 (2.24%)

15:05
12/10/18
12/10
15:05
12/10/18
15:05
Hot Stocks
Spartan Motors director James Sharman buys almost 16K shares of company stock »

Spartan Motors director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/10/18
12/10
15:05
12/10/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ASNA

Ascena Retail

$2.96

-0.05 (-1.66%)

15:04
12/10/18
12/10
15:04
12/10/18
15:04
Options
Ascena Retail options imply 27.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

WBT

Welbilt

$13.01

0.03 (0.23%)

15:01
12/10/18
12/10
15:01
12/10/18
15:01
Periodicals
Breaking Periodicals news story on Welbilt »

Hedgeye names Welbilt to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCTY

Paylocity

$62.89

0.63 (1.01%)

14:59
12/10/18
12/10
14:59
12/10/18
14:59
Conference/Events
Paylocity management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

OMI

Owens & Minor

$7.14

0.18 (2.59%)

14:54
12/10/18
12/10
14:54
12/10/18
14:54
Hot Stocks
Owens & Minor names Joseph S. Pekala chief information officer »

Owens & Minor, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVIA

Covia

$4.81

-0.45 (-8.56%)

14:50
12/10/18
12/10
14:50
12/10/18
14:50
Hot Stocks
Breaking Hot Stocks news story on Covia »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFIX

Stitch Fix

$26.91

0.57 (2.16%)

14:49
12/10/18
12/10
14:49
12/10/18
14:49
Options
Stitch Fix options imply 30.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AIG

AIG

$37.12

-0.77 (-2.03%)

14:45
12/10/18
12/10
14:45
12/10/18
14:45
Options
AIG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GRO

Agria

$0.00

(0.00%)

14:43
12/10/18
12/10
14:43
12/10/18
14:43
Hot Stocks
Agria agrees to pay $3M to settle fraud charges »

The SEC announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVA

Covanta

$15.44

-0.18 (-1.15%)

14:41
12/10/18
12/10
14:41
12/10/18
14:41
Conference/Events
Covanta management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEX

Terex

$28.31

(0.00%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Conference/Events
Terex management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

, WCG

WellCare

$235.10

-3.8 (-1.59%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on T. Rowe Price, WellCare »

T. Rowe Price reports…

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

WCG

WellCare

$235.10

-3.8 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$1.30

-0.09 (-6.47%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on Stage Stores »

Axar Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
General news
Dow recovers loss of over 500 points, turns positive »

At time of writing, the…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTES

Gates Industrial

$13.98

0.02 (0.14%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
Conference/Events
Gates Industrial management to meet with UBS »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

14:35
12/10/18
12/10
14:35
12/10/18
14:35
General news
Treasury Action: yields have mostly edged up as Wall Street recovers »

Treasury Action: yields…

GD

General Dynamics

$170.66

3.28 (1.96%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Hot Stocks
General Dynamics awarded $346.5M contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.